Evidence map›Paper›PMID 25807484›Full record

ArticleNature2015

Loss of δ-catenin function in severe autism.

Tychele N Turner, Kamal Sharma, Edwin C Oh, Yangfan P Liu, Ryan L Collins, Maria X Sosa, Dallas R Auer, Harrison Brand, Stephan J Sanders, Daniel Moreno-De-Luca and 13 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 2 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Large-scale discovery of neural enhancers for cis-regulation therapies.bioRxiv : the preprint server for biology · 2025
    Article
  9. Genome Sequencing Uncovers Additional Findings in Phelan-McDermid Syndrome.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Roles and regulation of δ-catenin in tumorigenesis and neuronal diseases.Frontiers in cell and developmental biology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 1 country.

Tychele N Turner1] Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2] Predoctoral Training Program in Human Genetics and Molecular Biology, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [3] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA.
Kamal SharmaSolomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Edwin C OhCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA.
Yangfan P LiuCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA.
Ryan L CollinsCenter for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Maria X Sosa1] Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA.
Dallas R Auer1] Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA.
Harrison Brand1] Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA [2] Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114 USA.
Stephan J Sanders1] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA [2] Department of Psychiatry, University of California, San Francisco, San Francisco, California 94158, USA.
Daniel Moreno-De-Luca1] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA [2] Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA.
Vasyl Pihur1] Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA.
Teri PlonaLeidos Biomedical Research, Inc., Frederick, Maryland 21702, USA.
Kristen PikeLeidos Biomedical Research, Inc., Frederick, Maryland 21702, USA.
Daniel R SoppetLeidos Biomedical Research, Inc., Frederick, Maryland 21702, USA.
Michael W SmithNational Human Genome Research Institute, Bethesda, Maryland 20892, USA.
Sau Wai CheungBaylor College of Medicine, Houston, Texas 77030, USA.
Christa Lese Martin1] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA [2] Autism &Developmental Medicine Institute, Geisinger Health System, Lewisburg, Pennsylvania 17837, USA.
Matthew W State1] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA [2] Department of Psychiatry, University of California, San Francisco, San Francisco, California 94158, USA.
Michael E Talkowski1] Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA [2] Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114 USA.
Edwin CookUniversity of Illinois at Chicago, Chicago, Illinois 60608, USA.
Richard HuganirSolomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Nicholas KatsanisCenter for Human Disease Modeling, Duke University, Durham, North Carolina 27710, USA.
Aravinda Chakravarti1] Center for Complex Disease Genomics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2] National Institute of Mental Health (NIMH) Autism Centers of Excellence (ACE) Genetics Consortium at the University of California, Los Angeles, Los Angeles, California 90095, USA.
University of California, Los Angeles · USDuke University · USJohns Hopkins Medicine · USLeidos Biomedical Research Inc. (United States)National Institute of Mental Health · USBaylor College of Medicine · USCenter for Human Genetics · USHarvard University · USJohns Hopkins University · USLeidos (United States) · USMassachusetts General Hospital · USNational Human Genome Research Institute · USUniversity of California, San Francisco · USUniversity of Illinois Chicago · US

Funding

A Comprehensive Approach to Identification of Autism Susceptibility GenesR01MH081754 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GESCHWIND, DANIEL H · 2008 to 2012
$14.6M
GENE DOSAGE IMBALANCE IN NEURODEVELOPMENTAL DISORDERSR01MH074090 · NIMH · GEISINGER CLINIC · PI David H. Ledbetter, CHRISTA LESE MARTIN · 2005 to 2026
$13.5M
Predoctoral Training Program in Human GeneticsT32GM007814 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 1985 to 2021
$10.6M
Center for Genomic and Phenomic Studies in AutismU24MH081810 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAJONCHERE, CLARA M · 2007 to 2011
$8.3M
Clinical Neuroscience Research Training Program in PsychiatryT32MH019961 · NIMH · YALE UNIVERSITY · PI Christopher John Pittenger · 1996 to 2026
$5.9M
HUMAN GENOMIC POLYMORPHISMSR01MH060007 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CHAKRAVARTI, ARAVINDA · 1998 to 2006
$4.5M
Schizophrenia Research FellowshipR25MH071584 · NIMH · YALE UNIVERSITY · PI Christopher John Pittenger · 2005 to 2026
$4.4M
The Role of Basa Bodies in Wnt SignalingR01DK075972 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KATSANIS, NICHOLAS · 2007 to 2015
$3.1M
Complex Genetic Architecture of Chromosomal Aberrations in AutismR00MH095867 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2014 to 2016
$747k
Complex Genetic Architecture of Chromosomal Aberrations in AutismK99MH095867 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2012 to 2013
$186k
NIDDK NIH HHS R01 DK075972NIGMS NIH HHS T32 GM007814NIMH NIH HHS 1U24MH081810NIMH NIH HHS 5R25MH071584-07NIMH NIH HHS K99 MH095867NIMH NIH HHS MH095867NIMH NIH HHS MH19961-14NIMH NIH HHS R00 MH095867NIMH NIH HHS R01 MH060007NIMH NIH HHS R01MH074090NIMH NIH HHS R01 MH081754NIMH NIH HHS R01MH081754NIMH NIH HHS R25 MH071584NIMH NIH HHS T32 MH019961NIMH NIH HHS U24 MH081810
6 · The paper itself

Abstract

Autism is a multifactorial neurodevelopmental disorder affecting more males than females; consequently, under a multifactorial genetic hypothesis, females are affected only when they cross a higher biological threshold. We hypothesize that deleterious variants at conserved residues are enriched in severely affected patients arising from female-enriched multiplex families with severe disease, enhancing the detection of key autism genes in modest numbers of cases. Here we show the use of this strategy by identifying missense and dosage sequence variants in the gene encoding the adhesive junction-associated δ-catenin protein (CTNND2) in female-enriched multiplex families and demonstrating their loss-of-function effect by functional analyses in zebrafish embryos and cultured hippocampal neurons from wild-type and Ctnnd2 null mouse embryos. Finally, through gene expression and network analyses, we highlight a critical role for CTNND2 in neuronal development and an intimate connection to chromatin biology. Our data contribute to the understanding of the genetic architecture of autism and suggest that genetic analyses of phenotypic extremes, such as female-enriched multiplex families, are of innate value in multifactorial disorders.

Indexed as

AnimalsAutistic DisorderBrainCateninsCells, CulturedChromatinDelta CateninDNA Copy Number VariationsEmbryo, MammalianExomeFemaleGene ExpressionGene Expression Regulation, DevelopmentalHippocampusHumansMaleCateninsChromatinDelta Catenin

Identifiers

PMID25807484
PMCPMC4383723
OpenAlexW2072782260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.